X inactivation phenotype in carriers of Pelizaeus-Merzbacher disease: skewed in carriers of a duplication and random in carriers of point mutations
- PMID: 10878666
- DOI: 10.1038/sj.ejhg.5200480
X inactivation phenotype in carriers of Pelizaeus-Merzbacher disease: skewed in carriers of a duplication and random in carriers of point mutations
Abstract
Pelizaeus-Merzbacher disease (PMD) is an X-linked recessive disease caused by coding sequence mutations in the PLP gene, sub-microscopic duplications of variable sizes including the PLP gene or very rarely deletions of the PLP gene. We analysed the X inactivation pattern in blood of PMD female carriers with duplications and with point mutations. In the majority of duplication carriers (7/11), the X chromosome bearing the duplication was preferentially inactivated, whereas a random pattern of X inactivation was detected in point mutation carriers (3/3), a deletion carrier (1/1), affected females (4/4) who did not have a recognised mutation and normal control females. However 2/5 non-carrier female relatives of patients with a duplication, had skewed X inactivation. The skewed pattern of inactivation observed in most duplication carriers and not in mutation carriers suggests a) that there is selection against those cells in which the duplicated X chromosome is active and b) other expressed sequences within the duplicated region rather than mutant PLP may be responsible. Since the skewed X inactivation did not segregate with the disease in two families and the pattern of X inactivation was variable among the duplication carriers, the pattern X inactivation is an unsuitable diagnostic tool for female carriers of PMD.
Similar articles
-
Genetic diagnosis of PLP gene duplications/deletions in patients with Pelizaeus-Merzbacher disease.Clin Genet. 2005 Nov;68(5):466-7. doi: 10.1111/j.1399-0004.2005.00522.x. Clin Genet. 2005. PMID: 16207216
-
Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: molecular mechanism and phenotypic manifestations.Ann Neurol. 1999 May;45(5):624-32. Ann Neurol. 1999. PMID: 10319885
-
Proteolipid protein 1 gene mutation in nine patients with Pelizaeus-Merzbacher disease.Chin Med J (Engl). 2008 Sep 5;121(17):1638-42. Chin Med J (Engl). 2008. PMID: 19024090
-
Random X-inactivation in a girl with duplication Xp11.21-p21.3: report of a patient and review of the literature.Am J Med Genet. 1999 Sep 3;86(1):44-50. Am J Med Genet. 1999. PMID: 10440827 Review.
-
The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.Expert Rev Mol Med. 2008 May 19;10:e14. doi: 10.1017/S1462399408000677. Expert Rev Mol Med. 2008. PMID: 18485258 Review.
Cited by
-
Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome.Am J Hum Genet. 2005 May;76(5):750-62. doi: 10.1086/429588. Epub 2005 Mar 8. Am J Hum Genet. 2005. PMID: 15756638 Free PMC article.
-
PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.Neurogenetics. 2005 Feb;6(1):1-16. doi: 10.1007/s10048-004-0207-y. Epub 2004 Dec 31. Neurogenetics. 2005. PMID: 15627202 Review.
-
Elucidation of the pathogenic mechanism and potential treatment strategy for a female patient with spastic paraplegia derived from a single-nucleotide deletion in PLP1.J Hum Genet. 2019 Jul;64(7):665-671. doi: 10.1038/s10038-019-0600-x. Epub 2019 Apr 19. J Hum Genet. 2019. PMID: 31004103
-
Neurogenetics of Pelizaeus-Merzbacher disease.Handb Clin Neurol. 2018;148:701-722. doi: 10.1016/B978-0-444-64076-5.00045-4. Handb Clin Neurol. 2018. PMID: 29478609 Free PMC article. Review.
-
A large X-chromosomal deletion is associated with microphthalmia with linear skin defects (MLS) and amelogenesis imperfecta (XAI).Am J Med Genet A. 2009 Aug;149A(8):1698-705. doi: 10.1002/ajmg.a.32968. Am J Med Genet A. 2009. PMID: 19610109 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials